Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today. One stock to keep an eye on is PT Telekomunikasi Indonesia (TLK) . TLK is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 10.54 right n ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leavin ...

CyberArk, however, belongs to the Security industry. Currently, this 10-stock industry is ranked #26. The industry has moved +22.8% so far this year. The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Creative Realities, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy). Over the past three months, the Zacks Consensus Estimate ...

Excelitas is a leading provider of advanced, life-enriching technologies that make a difference, serving global market leaders in the life sciences, advanced industrial, next-generation semiconductor and avionics end markets. Headquartered in Pittsburgh, PA, USA, Excelitas is an essential partner in the design, development and manufacture of advanced technologies, offering leading-edge innovation in sensing, detection, imaging, optics and specialty illumination for customers worldwide. Excelitas is at the f ...

Short interest has been building over the last month, despite the stock's 35% jump during that time, and now represents 5.9% of the stock's available float, so some of today's price action could be attributed to short covering. Call traders have been quick to the draw this morning. So far, the stock has seen 64,000 calls exchanged in comparison to just 7,609 puts, with overall options activity already at 4.2 times the average daily volume. The weekly 6/27 5.50-strike call is the most popular by far, with ne ...

This is an updated, more event-driven thesis expanding on my earlier analysis of REI. Ring Energy (NYSE: NYSE: REI ) is one of the most mispriced small-cap upstream oil names in the US market right now. This Analyst's Disclosure:I/we have a beneficial long position in the shares of REI either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stoc ...

Company Overview - Amarin (AMRN) shares increased by 27.3% to close at $16.04, with notable trading volume compared to typical sessions, and a 13.4% gain over the past four weeks [1][2] Recent Developments - Amarin licensed EU rights to its drug Vazkepa to Recordati, an Italy-based company, for $25 million upfront, with potential milestones of up to $150 million and ongoing royalties, significantly expanding Vazkepa's market reach and reducing EU-related costs by an expected $70 million over the next 12 months [2] Financial Performance - The company is expected to report a quarterly loss of $0.60 per share, a year-over-year change of -400%, with revenues projected at $45.19 million, down 33% from the previous year [3] - The consensus EPS estimate for the quarter has been revised 22.4% higher over the last 30 days, indicating a positive trend that may lead to price appreciation [4] Industry Context - Amarin is part of the Zacks Medical - Biomedical and Genetics industry, which includes other companies like MannKind (MNKD), which saw a 5.1% increase in its last trading session [5] - MannKind's consensus EPS estimate has remained unchanged at $0.04, reflecting a -20% change from the previous year, and it currently holds a Zacks Rank of 3 (Hold) [6]

Core Viewpoint - The article discusses the reliability of Wall Street analysts' recommendations, particularly focusing on Halliburton (HAL), and emphasizes the importance of using these recommendations in conjunction with other analytical tools for making investment decisions [1][5]. Group 1: Halliburton's Brokerage Recommendations - Halliburton has an average brokerage recommendation (ABR) of 1.74, indicating a position between Strong Buy and Buy, based on recommendations from 27 brokerage firms [2]. - Out of the 27 recommendations, 16 are classified as Strong Buy, accounting for 59.3%, while 2 are classified as Buy, making up 7.4% of the total recommendations [2]. Group 2: Limitations of Brokerage Recommendations - Solely relying on brokerage recommendations may not be advisable, as studies indicate they often fail to guide investors effectively towards stocks with high potential for price appreciation [5]. - Analysts from brokerage firms tend to exhibit a strong positive bias in their ratings, with five "Strong Buy" recommendations for every "Strong Sell" recommendation, which may mislead investors [6][10]. Group 3: Zacks Rank vs. ABR - The Zacks Rank is a proprietary stock rating tool that classifies stocks into five groups based on earnings estimate revisions, providing a more reliable indicator of near-term price performance compared to ABR [8][11]. - Unlike ABR, which is based solely on brokerage recommendations, the Zacks Rank is updated frequently to reflect changes in earnings estimates, making it a timely tool for predicting future price movements [12]. Group 4: Current Earnings Estimates for Halliburton - The Zacks Consensus Estimate for Halliburton's current year earnings has declined by 1.2% over the past month to $2.37, indicating growing pessimism among analysts regarding the company's earnings prospects [13]. - This decline in earnings estimates has resulted in a Zacks Rank of 4 (Sell) for Halliburton, suggesting caution despite the Buy-equivalent ABR [14].

Core Insights - Winnebago Industries reported revenue of $775.1 million for the quarter ended May 2025, reflecting a year-over-year decline of 1.4% and an EPS of $0.81 compared to $1.13 a year ago, with a slight revenue surprise of -0.03% against the Zacks Consensus Estimate [1] Financial Performance - The consensus EPS estimate was $0.79, resulting in an EPS surprise of +2.53% [1] - Winnebago's stock has returned -8.8% over the past month, underperforming the Zacks S&P 500 composite's +5.1% change, and currently holds a Zacks Rank 5 (Strong Sell) [3] Unit Deliveries and Revenue Breakdown - Total Motorhome RV unit deliveries were 1,431, exceeding the average estimate of 1,368 [4] - Total Towable RV unit deliveries were 9,495, below the average estimate of 10,218 [4] - Total Marine boat unit deliveries were 1,254, slightly below the average estimate of 1,303 [4] - Net Revenues for Motorhome RV were $291.20 million, surpassing the average estimate of $273.52 million but showing a -2.6% change year-over-year [4] - Net Revenues for Marine were $100.70 million, exceeding the average estimate of $97.21 million, with a +14.6% year-over-year change [4] - Net Revenues for Towable RV were $371.70 million, below the average estimate of $410.07 million, reflecting a -3.8% change year-over-year [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Towable RV was $35.40 million, below the average estimate of $40.40 million [4] - Adjusted EBITDA for Marine was $11.60 million, exceeding the average estimate of $10.49 million [4] - Adjusted EBITDA for Motorhome RV was $3 million, significantly below the average estimate of $11.21 million [4]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Oneok Inc. (OKE), and emphasizes the importance of using these recommendations in conjunction with other analytical tools like the Zacks Rank for making informed investment decisions [1][5][10]. Brokerage Recommendations - Oneok has an average brokerage recommendation (ABR) of 1.65, indicating a consensus between Strong Buy and Buy, based on recommendations from 17 brokerage firms [2][4]. - Out of the 17 recommendations, 11 are Strong Buy and 1 is Buy, which account for 64.7% and 5.9% of all recommendations, respectively [2]. Limitations of Brokerage Recommendations - Studies indicate that brokerage recommendations have limited success in guiding investors towards stocks with the best price increase potential [5]. - Analysts often exhibit a positive bias due to the vested interests of brokerage firms, leading to a disproportionate number of favorable ratings compared to negative ones [6][10]. Zacks Rank as an Alternative - The Zacks Rank is presented as a more reliable indicator of a stock's near-term price performance, based on earnings estimate revisions rather than brokerage recommendations [8][11]. - The Zacks Rank is updated more frequently and reflects the latest earnings estimates, making it a timely tool for predicting future price movements [12]. Current Earnings Estimates for Oneok - The Zacks Consensus Estimate for Oneok's current year earnings remains unchanged at $5.23, suggesting stability in analysts' views regarding the company's earnings prospects [13]. - Due to the unchanged consensus estimate and other factors, Oneok holds a Zacks Rank of 3 (Hold), indicating a cautious approach despite the Buy-equivalent ABR [14].